Nemoto, O., Furue, M., Nakagawa, H., Shiramoto, M., Hanada, R., Matsuki, S., Imayama, S., Kato, M., Hasebe, I., Taira, K., Yamamoto, M., Mihara, R., Kabashima, K., Ruzicka, T., Hanifin, J., & Kumagai, Y. (2016). the first trial of CIM331, a humanized antihuman interleukin‐31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double‐blind, placebo‐controlled study. British journal of dermatology, 174, 296–304. http://access.bl.uk/ark:/81055/vdc_100172213714.0x000044